Voyager Therapeutics, Inc. (15)

Browse by Contract Category

Contracts

AMENDMENT NO. 2 TO CONSULTING AGREEMENT (Filed With SEC on February 25, 2021)
First Amendment to Amended and Restated Option and License Agreement with Genzyme Corporation, dated September 20, 2020 (Filed With SEC on November 9, 2020)
Lease Agreement, by and between the Registrant and HCP/King 75 Hayden LLC, dated March 16, 2020 (Filed With SEC on March 19, 2020)
Description of Registrants Securities (Filed With SEC on March 3, 2020)
Termination Agreement, by and between Voyager Therapeutics, Inc. and Genzyme Corporation, dated June 14, 2019 (Filed With SEC on August 9, 2019)
Form of Non-Qualified Stock Option Agreement for Inducement Grant (Filed With SEC on February 26, 2019)
Transition, Separation, and Release of Claims Agreement, by and between the Company and Matthew P. Ottmer, dated as of February 12, 2020 (Filed With SEC on February 14, 2020)
Amendment No. 1 to Consulting Agreement, by and between the Corporation and Steven M. Paul, M.D., dated July 9, 2019 (Filed With SEC on November 6, 2019)
Amendment No. 1 to Consulting Agreement, by and between the Corporation and Dinah Sah, dated September 16, 2019 (Filed With SEC on November 6, 2019)
Employment Agreement, by and between Voyager Therapeutics, Inc. and Omar Khwaja, M.D., Ph.D, dated May 20, 2019 (Filed With SEC on August 9, 2019)
Amended and Restated Option and License Agreement, by and between Voyager Therapeutics, Inc. and Genzyme Corporation, dated June 14, 2019 (Filed With SEC on August 9, 2019)
Amendment No. 1 to the Collaboration and License Agreement, by and between Voyager Therapeutics, Inc. and Neurocrine Biosciences, Inc., dated June 14, 2019 (Filed With SEC on August 9, 2019)
Consulting Agreement, by and between Voyager Therapeutics, Inc. and Dinah Sah, Ph.D., dated June 28, 2019 (Filed With SEC on August 9, 2019)
Retirement Agreement, by and between the Company and Dinah Sah, dated as of May 20, 2019 (Filed With SEC on May 21, 2019)
Employment Agreement, by and between the Registrant and Robert W. Hesslein, dated January 15, 2019 (Filed With SEC on May 7, 2019)